SCHEMBL9563182

SCHEMBL9563182

CS(=O)(=O)Nc1cccc(OCCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.53
SLC6A4 P31645 3/20 0.53
ADRA1D P25100 2/20 0.53
ADRA1A P35348 2/20 0.53
ADRA1B P35368 2/20 0.53
BCHE P06276 9/20 0.51
MET P08581 1/20 0.49
DRD4 P21917 2/20 0.48
DRD3 P35462 2/20 0.48
HTR1A P08908 2/20 0.47
HTR7 P34969 1/20 0.47
PARP14 Q460N5 1/20 0.47
NPC1 O15118 1/20 0.46
MLNR O43193 1/20 0.46
NR1I2 O75469 1/20 0.46
EGFR P00533 1/20 0.46
LMNA P02545 1/20 0.46
ERBB2 P04626 1/20 0.46
FYN P06241 1/20 0.46
CHRM2 P08172 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9563314 0.89 BCHE (0.53) DRD2SLC6A4ADRA1DADRA1AADRA1B
SCHEMBL9563263 0.83 BCHE (0.52) DRD2SLC6A4ADRA1DADRA1AADRA1B
Hydrochloric Acid SCHEMBL9563254 0.83 BCHE (0.51) DRD2SLC6A4ADRA1DADRA1AADRA1B
SCHEMBL9563296 0.82 BCHE (0.48) DRD2SLC6A4ADRA1DADRA1AADRA1B
SCHEMBL9563285 0.81 BCHE (0.46) DRD2SLC6A4ADRA1DADRA1AADRA1B
SCHEMBL9563179 0.81 BCHE (0.56) DRD2SLC6A4ADRA1DADRA1AADRA1B
SCHEMBL9563272 0.81 BCHE (0.53) DRD2SLC6A4ADRA1DADRA1AADRA1B
SCHEMBL9591248 0.80 BCHE (0.47) DRD2SLC6A4ADRA1DADRA1AADRA1B
SCHEMBL9563339 0.80 BCHE (0.55) DRD2SLC6A4ADRA1DADRA1AADRA1B
SCHEMBL9563267 0.80 BCHE (0.53) DRD2SLC6A4ADRA1DADRA1AADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0529365-A1 Diarylmethoxypiperidine derivatives Kaken Pharmaceutical Co., Ltd. (JP) 1993-03-03 EP disclosed
US-5190959-A Antihistamines, antiallergens, treatment of ischemic heart disease KAKEN PHARMACEUTICAL CO. LTD. (JP) 1993-03-02 US disclosed